Transcatheter aortic valve Implantation
Transcatheter aortic valve Implantation is a medical device with 32 clinical trials. Currently 10 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
10
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Myval THV Series With Guideline-Directed Medical Therapy in Participants With Moderate Aortic Stenosis
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis
Management of Patients With New Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Clinical Trials (32)
Comparison of Myval THV Series With Guideline-Directed Medical Therapy in Participants With Moderate Aortic Stenosis
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis
Management of Patients With New Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Predictive Value of Pre-TAVI Infrahissian Conduction Time in the Occurrence of Complete Atrioventricular Block
Transcatheter Aortic Valve Implantation Registry at the National Research Center for Cardiac Surgery, Nur-Sultan, Kazakhstan
Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement
The Leipzig TAVI Registry
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
SwissTAVI Registry
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.
NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International Experience
The Nordic Aortic Valve Intervention Trial
Cognitive Outcome After Surgical and Transcatheter Aortic Valve Replacement
Outcome Prediction in Patients With Aortic Stenosis After TAVI
Prognostic Factors in NOP-LBBB After TAVI
Cardiac Output, Cerebral Perfusion and Cognition in Patients Undergoing TAVI
The Prospective Segeberg TAVI Registry
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 32